Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease

OBJECTIVE: To determine whether oral quinacrine increases survival in sporadic Creutzfeldt-Jakob disease (sCJD). METHODS: This NIH/National Institute on Aging–funded, double-blinded, placebo-controlled, stratified randomization treatment trial was conducted at the University of California, San Franc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Geschwind, Michael D., Kuo, Amy L., Wong, Katherine S., Haman, Aissa, Devereux, Gillian, Raudabaugh, Benjamin J., Johnson, David Y., Torres-Chae, Charles C., Finley, Ron, Garcia, Paul, Thai, Julie N., Cheng, Hugo Q., Neuhaus, John M., Forner, Sven A., Duncan, Jacque L., Possin, Katherine L., DeArmond, Stephen J., Prusiner, Stanley B., Miller, Bruce L.
Formato: Artigo
Lenguaje:Inglês
Publicado: Lippincott Williams & Wilkins 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4211922/
https://ncbi.nlm.nih.gov/pubmed/24122181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182a9f3b4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares